Skip to Main Content

Paper Details

Moving pan-cancer studies from basic research toward the clinic.
Nat Cancer
38
2021
cancer, cancers, silver
Author NameAffiliation
Feng ChenWashington University in St. Louis
Feng ChenWashington University in St. Louis
Feng ChenSiteman Cancer Center, Washington University in St. Louis
Feng ChenWashington University in St. Louis
Feng ChenSiteman Cancer Center, Washington University in St. Louis
Feng ChenWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Matthew H BaileyHuntsman Cancer Institute, University of Utah
Matthew H BaileyEccles Institute of Human Genetics, University of Utah
Yize LiWashington University in St. Louis
Yize LiMcDonnell Genome Institute, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingSiteman Cancer Center, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingMcDonnell Genome Institute, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingSiteman Cancer Center, Washington University in St. Louis
Li DingWashington University in St. Louis
Li DingMcDonnell Genome Institute, Washington University in St. Louis
  • 1 - 28

Datasets